Skip to search formSkip to main contentSkip to account menu

HPV-6-targeting Immunotherapeutic Vaccine INO-3106

Known as: HPV-6 E6/E7 DNA Vaccine INO-3106, HPV-6-targeting Immunotherapeutic INO-3106, INO-3106 
A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus subtype 6 (HPV-6), with potential immunostimulating and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background: Recurrent respiratory papillomatosis (RRP) is a rare disorder characterized by the generation of papillomas of the… 
Highly Cited
2019
Highly Cited
2019
Antibiotic‐free methods hold particular promise for preventing and controlling multidrug‐resistant (MDR) bacterial infection via… 
2018
2018
Summary Trafficking of macromolecular immunotherapy agent into the tumor microenvironment (TME) is a challenging issue. In the… 
2016
2016
OBJECTIVE To investigate the correlation between the positive rate of high risk human papillomavirus(HPV)mRNA E6/E7 and cervical… 
2012
2012
Purpose: To evaluate IL13Ra2 as an immunotherapeutic target for eliminating glioma stem–like cancer initiating cells (GSC) of… 
Highly Cited
2008
Highly Cited
2008
B7-H1 (B7 homologue 1, PD-L1), expressed on the surface of tumor cells or antigen-presenting cells in the tumor microenvironment…